Mechanism of cholesterol gallstones formation.
D000818:Animals; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000096:biosynthesis / Q000378:metabolism; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D002769:Cholelithiasis / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D002784:Cholesterol / Q000378:metabolism*; D002791:Cholesterol, Dietary / Q000009:adverse effects / Q000378:metabolism; D002914:Chylomicrons / Q000378:metabolism; D002940:Circadian Rhythm; D002994:Clofibrate / Q000009:adverse effects; D004032:Diet / Q000009:adverse effects; D004285:Dogs; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D009765:Obesity / Q000150:complications; D051381:Rats; D012008:Recurrence; D012737:Sex Factors; D012995:Solubility
D001647:Bile Acids and Salts; D002791:Cholesterol, Dietary; D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002635:Chenodeoxycholic Acid; D002784:Cholesterol; D002994:Clofibrate